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Level One Evidence on the value of adult tonsillectomy versus non-surgical management 41 
remains scarce. Before embarking on a costly national randomised controlled trial, it is 42 
essential to establish its feasibility. 43 
Design 44 
Feasibility study with in-depth qualitative and cognitive interviews.  45 
Setting 46 
ENT staff and patients were recruited from nine hospital centres across England and 47 
Scotland. 48 
Participants 49 
Patients who were referred for tonsillectomy (n=15), a convenience sample of General 50 
Practitioners (n=11) and Ear, Nose and Throat staff (n=22).  51 
Main outcome measures 52 
1. To ascertain whether Ear, Nose and Throat staff would be willing to randomise patients 53 
to the treatment arms.  54 
2. To assess General Practitioners’ willingness to refer patients to the NAtional Trial of 55 
Tonsillectomy IN Adults (NATTINA) centres.  56 
3. To assess patients’ willingness to be randomised and the acceptability of the deferred 57 
surgery treatment arm. 58 
4. To ascertain whether the study could progress to the pilot trial stage. 59 
 60 
Results 61 
Ear, Nose and Throat staff and General Practitioners were willing to randomise patients to 62 
the proposed NATTINA. Not all ENT staff were in equipoise concerning the treatment 63 
pathways. Patients were reluctant to be randomised into the deferred surgery group if they 64 
had already waited a substantial time before being referred. 65 
Conclusions 66 
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Findings suggest that the National Trial of Tonsillectomy IN Adults may not be feasible. 67 
Proposed methods could not be realistically assessed without a pilot trial. Due to the 68 
importance of the question, as evidenced by NATTINA clinicians, and strong support from 69 
ENT staff, the pilot trial proceeded, with modifications. 70 
Introduction 71 
The role of tonsillectomy in managing adult sore throat remains uncertain, and despite 72 
demonstrable compliance with SIGN guidance (1), UK regional variation in tonsillectomy 73 
rates persist (2). Questions that stakeholders wish to answer relate to the relative costs and 74 
benefits of tonsillectomy against non-surgical pathways. The 2014 Cochrane review (3) 75 
identified two evaluable adult trials, with just 156 participants, both in Finland, and 76 
concluded that reasonable levels of evidence on effectiveness were still only available for 77 
children. Low recruitment rates into surgical randomised controlled trials (RCTs) threaten 78 
external validity of findings (4). Integration of qualitative research can improve feasibility, 79 
design and conduct (5). Additionally, recruitment processes should be tested before patients 80 
are enrolled to a trial (4, 6) However there is a paucity of research examining key 81 
stakeholders’ experience of recurrent sore throats and attitudes towards management in 82 
adults. 83 
The NAtional Trial of Tonsillectomy In Adults (NATTINA) consists of this feasibility study, an 84 
internal pilot and definitive trial of 600 adults, with embedded qualitative process evaluation 85 
(7). This paper, reporting the main findings from the feasibility study, follows a linked paper 86 
(Reference the linked NATTINA part 1 paper submitted separately) where stakeholders 87 
were asked their views of recurrent sore throat, tonsillitis and their management as part of 88 
this feasibility study. Gaining stakeholder perspectives of these issues was considered to 89 
be an essential part of the study, however the depth of findings allowed for two linked, but 90 
discrete papers to be completed. 91 
In the main NATTINA trial participants will be randomly allocated into immediate or deferred 92 
surgery. Our experience of a randomised trial of tonsillectomy in children (8, 9), together with 93 
other published Ear, Nose and Throat (ENT) surgical trials (3), highlighted the problem of 94 
retaining participants in a non-surgical cohort. These findings along with patient and public 95 
engagement have influenced our trial design and decision to use deferred surgery as the 96 
conservative management option rather than no surgery.  97 
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The aim of the NATTINA feasibility study was to assess the practicality of the proposed 98 
internal pilot and full scale trial. The specific objectives of the study were to establish: 99 
standard NHS ENT staff willingness to randomise patients to the treatment arms; the 100 
feasibility of patient identification and the eligibility criteria ; GPs’ willingness to refer 101 
patients to standard NHS NATTINA centres; patients’ willingness to be randomised and 102 
their potential acceptance of the deferred surgery treatment arm, as well as views on the 103 
proposed data collection methods, including weekly sore throat alert prompts and Sore 104 
Throat Alert Returns (STARs)(7).  105 
Methods 106 
Ethical considerations 107 
Favourable ethical opinion was given by proportionate review of the NRES committee – 108 
Fulham, London on 16 June 2014 (14/LO/1115). 109 
Sampling 110 
Sampling of patients was purposive, seeking maximum demographic 111 
(age/sex/duration/severity). A convenience sample was selected from NHS staff likely to be 112 
involved in the nine UK standard NHS NATTINA centres and GPs from the surrounding 113 
catchment areas. Sample size was determined by reaching data saturation where the 114 
research team deemed no new themes to have emerged in three consecutive interviews 115 
(10). Based on previous work by the investigators (11), it was estimated that this plateau 116 
would occur at around 45+ interviews: 20 ENT staff, 15 patients and 10 GPs. 117 
Procedure 118 
ENT staff identified patients who met the proposed NATTINA eligibility criteria (7). 119 
Healthcare professionals (otolaryngologists, research nurses, nurse practitioners, clinic 120 
managers and general practitioners) who were likely to be involved at each NATTINA main 121 
trial site were identified. Written informed consent was taken before interviews. 122 
In-depth interviews took place over 5 months (August 2014 to January 2015) and lasted up 123 
to 30 minutes. Interviews were based on flexible topic guides derived from the literature, 124 
issues raised by our Patient and Public Involvement group and in conjunction with the study 125 
Otolaryngologists and GP. Themes and topics explored included: symptoms and effects of 126 
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recurrent sore throats, management of recurrent sore throat, experience of participation and 127 
willingness to participate in research.  128 
Data management and analysis 129 
Interviews were recorded and transcribed. Framework analysis (12) was supported by NVivo 130 
software (13). Data were repeatedly read and coded by an experienced qualitative 131 
researcher LM within a framework of a priori issues and those identified by participants or 132 
which emerged from the data. Analysis was discussed at regular meetings of the research 133 
team to identify areas for closer consideration (including negative case analysis) and to 134 
enhance credibility of the thematic framework and interpretation (14). Qualitative work 135 
explored influences on both patient recruitment and on the implementation of the study 136 
interventions. Analysis of barriers and facilitators to 1) trial participation and 2) the 137 
normalisation of study interventions in clinical practice was informed by Normalization 138 
Process Theory (15).  139 
Results 140 
All nine study centres participated, with 48 participants interviewed. Staff were 9 ENT 141 
consultants, 1 ENT trainee (registrar), 6 research nurses, 4 nurse practitioners and 2 trial 142 
managers. Seven centres received 39 patient ‘expression of interest’ forms yielding 15 143 
(38%) patient interviews. Twelve patients were interviewed face-to-face and due to work 144 
commitments, 3 patients opted to be interviewed by telephone. At the time of their interview 145 
the patients were on the waiting list for a tonsillectomy; this was considered to be the most 146 
efficient form of recruitment. Contact details for 40 GPs were received from 7 of the centres; 147 
11 (28%) GPs were recruited. All but one of the ENT staff and GPs were interviewed by 148 
telephone. Results are presented by study objective with individual participant quotations 149 
used to support and illustrate the findings. 150 
ENT staff willing to consider participation in NATTINA 151 
All interviewed staff were willing to participate in the NATTINA trial and to randomise 152 
patients, however, they questioned whether patients would be willing to accept 153 
randomisation: 154 
We don't know which arm you're better off being in. So I'm very happy 155 
randomising the patients. I don't know how acceptable it is to the patients 156 
we randomise  157 
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Most ENT staff felt the research would address the fundamental question of whether 158 
tonsillectomy in adults was beneficial, not only to the patient but also for the NHS in terms 159 
of cost-effectiveness. 160 
I mean, whilst we’ve driven down the frequency of tonsillectomy and the so-161 
called savings there, what we do see is an increase in people coming into 162 
hospital with acute tonsillitis  163 
The above respondent felt the implications of these ‘so-called savings’ were having a 164 
negative impact on patients’ health. Many ENT staff felt that the evidence for surgery 165 
versus conservative management was scarce: 166 
..A lot of decisions are being made about how to treat patients with 167 
recurrent acute tonsillitis which don’t have a robust evidence base behind 168 
them  169 
It was felt that new research evidence had the potential to improve patient care and 170 
practice. 171 
Potential participants willing to take part in NATTINA 172 
Patients’ views 173 
The majority of patients reported that they would not consider taking part in the proposed 174 
trial as they did not want the risk of being randomised to deferred surgery:  175 
 ..I’d be anxious to have the surgery sooner because I’ve been suffering 176 
since I was young...to wait even more and to miss more time off work, no I 177 
really think it’s time that they come out  178 
Many patients reported the negative effects of tonsillitis and felt that to defer surgery would 179 
be too detrimental to their quality of life: 180 
It had too much of an impact. It was happening at least twice a month as 181 
well, so it was really interfering with my attendance and stuff, and work, and 182 
money  183 
Some patients stated they might consider randomisation if they knew they could opt out of 184 
the deferred surgery group without having to go back to the bottom of the surgery waiting 185 
list if their symptoms worsened: 186 
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Yeah, that would probably be better. I wouldn’t want to be in the position 187 
where you have to wait and wait and wait to get re-referred and re-seen 188 
and stuff like that 189 
GPs’ views 190 
Many GPs believed that tonsillectomy in adults was a rare occurrence and they were under 191 
pressure to minimise referrals to secondary care. Some felt that adults were not looking for 192 
surgery: 193 
We try really hard not to send our patients because for the vast majority of 194 
patients they are unlikely to have their tonsils removed as adults  195 
However, those GPs that did refer patients felt the patients would probably be unwilling to 196 
be randomised as, having had to meet strict criteria before being referred(1), GPs felt that by 197 
the time the patient reaches the consultant they have an expectation of surgery: 198 
Certainly, I do not refer very many people, and the ones that I do, I do not 199 
think they would be willing to say “Great, I will enter a trial and wait up to 200 
another two years”  201 
As with the actual patients themselves, a couple of GPs reported that the option to change 202 
to immediate surgery if withdrawing from the deferred surgery group may persuade some 203 
patients to be randomised: 204 
I think that sounds very reasonable. I like the get out clause in the control 205 
arm, but I think it’s a very good idea to delay surgery anyway  206 
ENT staff views 207 
Most ENT staff concurred with GPs’ views of patients having expectation of surgery, not 208 
willing to defer surgery, or that they may be more willing to be randomised with a quicker 209 
‘opt-out’ route: 210 
Most patients in my experience do come with the view point that they would 211 
like the tonsils removed ‘cos a lot of them have already discussed it with 212 
the GP. So asking them to wait another year, I’m not sure if we’ll be able to 213 
recruit that many patients to that arm  214 
 215 
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Treatment pathways acceptable and adequately defined  216 
Patients’ views  217 
Participants’ reactions were closely related to whether they would be willing to be 218 
randomised and take part in the trial. That is, they were not willing to accept the risk of 219 
being randomised into the deferred surgery group as they found that pathway, as originally 220 
presented, to be unacceptable: 221 
I don’t even want to imagine what that would be like [deferred surgery]. 222 
Tonsillitis is honestly one of the worst illnesses I’ve had, and needs to be 223 
treated sooner rather than later.  224 
GPs’ views 225 
A few GPs felt that deferring surgery was a good idea but were unsure how it would be 226 
accepted by patients: 227 
I think that’s entirely appropriate. My only concern is the non-surgical 228 
treatment plan you might lose patients who then go on to decide that they 229 
want surgery… because they are having difficulty with their symptoms  230 
ENT staff  231 
Some ENT staff identified concerns over the treatment pathways with one practitioner 232 
worried that patients may feel they were being disadvantaged by being randomised to the 233 
deferred surgery arm; one research nurse felt that delaying a patient’s surgery was not 234 
acceptable: 235 
Thinking that somebody’s going to delay that [a tonsillectomy] for one to 236 
two years is quite horrifying really  237 
Outcome measures and data collection methods feasible and adequately defined 238 
Patients’ views 239 
Most patients found the outcome measures and data collection methods acceptable with 240 
most happy to use electronic methods (email and text) to communicate and complete tasks. 241 
A small selection of patients reported that they preferred paper-based methods but 242 
understood that email would be quicker and cheaper. 243 
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Patients reported that they would be willing to complete the STAR text alerts, however 244 
some felt weekly to be too onerous: 245 
I’d probably get quite irritated after a while like weekly seems just too close 246 
together. Maybe like fortnightly would be a better idea  247 
ENT Staff views 248 
Some staff felt that data collection was an on-going research issue and that some patients 249 
may find the methods intensive. Paper-based methods were stated as rarely successful 250 
and there was concern weekly alerts may be too burdensome. 251 
However, there was general consensus that electronic methods would be suitable: 252 
The demographic of recurrent tonsillitis tends to be younger patients, so I 253 
think things like text messaging questionnaire [sic], etc. would probably 254 
give you a higher response rate than a traditional paper-based through the 255 
post questionnaire. 256 
However, one staff member was concerned that not everyone would have access to the 257 
internet. Additionally it was suggested that patients, not currently suffering symptoms, 258 
would be disinclined to respond to prompts for outcome data. Furthermore, staff from two of 259 
the centres reported high numbers of patients whose first language was not English: 260 
The only issue is the language barrier for some patients, which where I 261 
work, my patient population, that's quite a big issue. 262 
Process of patient identification and recruitment feasible and adequately defined 263 
GPs’ views 264 
Most GPs stated that they were willing to refer patients to centres participating in NATTINA 265 
but there were some queries about how the referral process would work: 266 
It is maybe thinking about, in terms of the study design, people at the point 267 
of referral knowing, or the point they receive their outpatient at clinic is 268 
probably better…that gives them the chance to almost revisit why they 269 
have been referred, and what their expectations are . 270 
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Many GPs thought it beneficial for practices to be study aware so they could provide 271 
patients with information to ensure that patients are referred without a prior expectation of 272 
tonsillectomy. 273 
Discussion 274 
Synopsis of key findings 275 
Results suggest that ENT staff are strongly supportive of a trial of tonsillectomy in adults 276 
and are willing to randomise patients meeting SIGN criteria(1) . However patients meeting 277 
NATTINA eligibility criteria expressed reluctance to be randomised because of 278 
unwillingness to enter the deferred surgery arm of the study. Patients indicated that they 279 
might be more willing to be randomised if there was a clear route back to surgical 280 
intervention - at the time of their interview most patients had received a surgery date for 281 
their tonsillectomy or one was imminent. This inevitably contributed to their negative 282 
perception of deferral. There is a lot of emotion associated with surgery and, whilst waiting, 283 
patients are often preoccupied with issues such as feeling ‘in limbo’, ‘lives being on hold’ 284 
and ‘clock-watching’(16, 17).  285 
Many GPs believed tonsillectomy in adults was a rare occurrence. However, in 2013-14, 286 
20,607 adults over the age of 16 years received a tonsillectomy in England i.e. the average 287 
GP will refer 2 patients (who receive a tonsillectomy) every 3 years (18). In this study it was 288 
reported that some GP practices were encouraged to minimise tonsillectomy referrals; it 289 
has been estimated that two thirds of Clinical Commissioning Groups restrict referrals for 290 
treatments they deem to be non-urgent or of low clinical value (19). This means that 291 
treatment control pathways have changed, moreover, some GPs stated they very rarely 292 
saw patients who were eligible for referral.  293 
Implications for pilot trial 294 
The feasibility trial allowed for timely modifications and valuable stakeholder insights. The 295 
Trial Management Group assessed the feasibility results and implemented several 296 
changes, specifically around movement between treatment arms. The proposal that 297 
patients who wanted to switch from the deferred surgery group could do so without going 298 
back on the waiting list resulted in positive feedback from patients. This proposal arose 299 
from a research team meeting to discuss interim analysis of the feasibility study and 300 
feedback from the patient involvement panel. It was proposed that reduced waiting for 301 
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patients who decide to switch may be enough of an incentive for some patients to 302 
participate. Random allocation to treatment arms within NATTINA will be concealed from 303 
investigators, GPs, ENT staff and participants in order to eliminate bias however, anything 304 
which facilitates movement between arms has the potential to impact on the intention to 305 
treat analysis; therefore, it was recommended that a per-treatment analysis was also 306 
conducted and that numbers switching are monitored throughout the recruitment period to 307 
assess impact on trial design. The following changes were also recommended: 308 
 Emphasis on the need for a trial in the patient information materials 309 
 Spread the recruitment to the pilot to a larger number of centres 310 
 Refinement of baseline questionnaire 311 
 Translation of patient study information to Urdu, Gujarati, Punjabi and Bengali 312 
 Clarification of clinical pathway for control (deferred-surgical) arm for participants 313 
 Extra attention to dissemination of information about the study to GPs, to mitigate 314 
patient expectation that referral equates to tonsillectomy 315 
 316 
Strengths and limitations 317 
A unique strength of this study is the quantity of appropriately representative data from 318 
multiple stakeholders. However, the fact that we selected patients who had already decided 319 
to proceed with a tonsillectomy inevitably must have influenced their perception of the 320 
study.  321 
Conclusions  322 
The proposed methods were generally acceptable notwithstanding some concern about the 323 
weekly frequency of sore throat episode recording. ENT and research staff stated that the 324 
acceptance of the data collection methods could not realistically be assessed until a pilot 325 
trial was in operation. A decision-making meeting was scheduled for the end of the 326 
feasibility study to review the findings and to confirm that there was sufficient support from 327 
those interviewed to allow the project to continue on to the NATTINA internal pilot phase. 328 
The decision to continue was approved by the NATTINA Trial Steering Committee and HTA 329 
informed. Barriers to recruitment which may emerge include: fewer eligible patients than 330 
expected, smaller percentage of patients agreeing to participate, internal staff problems, (20) 331 
and lack of equipoise (21).  332 
333 
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